Pregnancy and the eye.
Khong Edmund W C, Chan Helen H L, Watson Stephanie L, Lim Lyndell L
AI Summary
Pregnancy impacts ocular conditions like glaucoma, with treatment safety often unknown. Selective laser trabeculoplasty is preferred for glaucoma, and anti-VEGFs are avoided early for diabetic retinopathy, highlighting research and multidisciplinary care needs.
Abstract
Purpose of review: The aim of this study was to summarize common eye changes that may occur during pregnancy, and how pregnancy may affect preexisting eye conditions such as glaucoma and diabetic retinopathy. Challenges and complexities surrounding the treatment of these eye conditions during pregnancy are also highlighted.
Recent findings: Refractive changes are common and may persist in the postpartum in patients with keratoconus. Although new medical and surgical glaucoma treatments are available, their safety in pregnancy is unknown. Limited use of topical and systemic glaucoma therapies is recommended, with a preference for selective laser trabeculoplasty as first line treatment in appropriate cases. The impact of pregnancy on diabetic retinopathy remains unclear. Although anti-vascular endothelial growth factor agents are first-line treatment for sight-threatening diabetic retinopathy, their effect on the developing foetus remains unknown and are therefore best avoided in the first and second trimesters. Noninfectious uveitis tends to become less active during pregnancy, allowing the potential tapering of systemic therapy and the use of local topical or injected corticosteroid treatment for active disease as required.
Summary
Significant changes can occur to the eye during pregnancy, wherein the optimal treatment for many ocular conditions remains uncertain, highlighting the need for further research to develop clear recommendations that best balance the need to preserve the mother's sight, and the health of the developing foetus. The need for preconception planning, and collaborative multidisciplinary care between the obstetrician, physician, ophthalmologist and paediatrician is paramount.
MeSH Terms
Shields Classification
Key Concepts5
The safety of new medical and surgical glaucoma treatments during pregnancy is unknown.
Limited use of topical and systemic glaucoma therapies is recommended during pregnancy, with a preference for selective laser trabeculoplasty as first-line treatment in appropriate cases.
The impact of pregnancy on diabetic retinopathy remains unclear.
Anti-vascular endothelial growth factor agents, which are first-line treatment for sight-threatening diabetic retinopathy, are best avoided in the first and second trimesters of pregnancy due to unknown effects on the developing foetus.
Noninfectious uveitis tends to become less active during pregnancy, allowing potential tapering of systemic therapy and the use of local topical or injected corticosteroid treatment for active disease as required.
Related Articles5
Pregnancy and glaucoma.
ReviewIncreasing healthcare costs: can we influence the costs of glaucoma care?
ReviewGlaucoma clinical trials and what they mean for our patients.
ReviewNanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
Review21st century glaucoma care.
ReviewIs this article assigned to the wrong chapter(s)? Let us know.